Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4254/wjh.v9.i5.288 http://scihub22266oqcxt.onion/10.4254/wjh.v9.i5.288 C5316849!5316849!28261386     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Hepatol 2017 ; 9 (5): 288-92 Nephropedia Template TP {{tp|p=28261386|t=2017. Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?|pdf=|usr=}}{{28261386}} gab.com Text Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis JO: World J Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=28261386 #FOAvip AIM: To reduce hepatic and extrahepatic complications of chronic hepatitis C in kidney transplant recipients. METHODS: We conducted a systematic review of kidney only transplant in patients with hepatitis C and advanced fibrosis. RESULTS: The 5 year patient survival of kidney transplant recipients with and without hepatitis C cirrhosis ranged from 31% to 90% and 85% to 92%, respectively. Hepatitis C kidney transplant recipients had lower 10-year survival when compared to hepatitis B patients, 40% and 90% respectively. There were no studies that included patients with virologic cure prior to kidney transplant that reported post-kidney transplant outcomes. There were no studies of direct acting antiviral therapy and effect on patient or graft survival after kidney transplantation. CONCLUSION: Data on kidney transplant only in hepatitis C patients that reported inferior outcomes were prior to the development of potent direct acting antiviral. With the development of potent directing acting antiviral therapy for hepatitis C with high cure rates studies are needed to determine if patients with hepatitis C, including those with advanced fibrosis, can undergo kidney transplant alone with acceptable long term outcomes. Twit Text FOAVip Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis ????World J Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=28261386 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28261386 #FOAvip English Wikipedia <ref>{{Cite pmid|28261386}}</ref> Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis? #MMPMID28261386 Shah NJ; Russo MW World J Hepatol 2017[Feb]; 9 (5): 288-92 PMID28261386show ga AIM: To reduce hepatic and extrahepatic complications of chronic hepatitis C in kidney transplant recipients. METHODS: We conducted a systematic review of kidney only transplant in patients with hepatitis C and advanced fibrosis. RESULTS: The 5 year patient survival of kidney transplant recipients with and without hepatitis C cirrhosis ranged from 31% to 90% and 85% to 92%, respectively. Hepatitis C kidney transplant recipients had lower 10-year survival when compared to hepatitis B patients, 40% and 90% respectively. There were no studies that included patients with virologic cure prior to kidney transplant that reported post-kidney transplant outcomes. There were no studies of direct acting antiviral therapy and effect on patient or graft survival after kidney transplantation. CONCLUSION: Data on kidney transplant only in hepatitis C patients that reported inferior outcomes were prior to the development of potent direct acting antiviral. With the development of potent directing acting antiviral therapy for hepatitis C with high cure rates studies are needed to determine if patients with hepatitis C, including those with advanced fibrosis, can undergo kidney transplant alone with acceptable long term outcomes. äIs it time to rethink combined liver-kidney transplant in hepatitis C (epmc).pdf DeepDyve Pubget Overpricing